Search research articles
Contact Us
Filters
Showing results (41-50 of 51) with videos related to
Page
of 6
Sort By:
Transactions of the American Association of Genito-Urinary Surgeons
|
January 1, 1972
The syndrome of hypertension, hyperreninemia and secondary aldosteronism associated with renal juxtaglomerular cell tumor (primary reninism)
J W Conn, E L Cohen, W J McDonald, et al.
The Journal of Urology
|
March 1, 1973
The syndrome of hypertension, hyperreninemia and secondary aldosteronism associated with renal juxtaglomerular cell tumor (primary reninism)
J W Conn, E L Cohen, W J McDonald, et al.
Clinical Science and Molecular Medicine. Supplement
|
August 1, 1973
Primary reninism: hypertension, hyperreninaemia and secondary aldosteronism due to juxtaglomerular renal cell tumours
J W Conn, E L Cohen, W J McDonald, et al.
The Journal of Laboratory and Clinical Medicine
|
November 1, 1971
Visualization of aldosterone-producing tumors (APT) by scintillation scanning (SS) employing tracer amounts of 131 -iodocholesterol
J W Conn, E L Cohen, C P Lucas, et al.
Obesity Research
|
August 4, 1998
Clinical trial design for obesity agents: a workshop report
J W Anderson, F X Pi-Sunyer, E Danforth, et al.
Archives of Internal Medicine
|
November 1, 1972
Primary reninism. Hypertension, hyperreninemia, and secondary aldosteronism due to renin-producing juxtaglomerular cell tumors
J W Conn, E L Cohen, C P Lucas, et al.
Transactions of the Association of American Physicians
|
January 1, 1972
The syndrome of hypertension, hyperreninemia and secondary aldosteronism associated with renal juxtaglomerular cell tumor (primary reninism)
J W Conn, E L Cohen, W J McDonald, et al.
JAMA
|
January 26, 1999
Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat: a randomized controlled trial
M H Davidson, J Hauptman, M DiGirolamo, et al.
International Journal of Obesity
|
January 1, 1989
Use of fluoxetine, a selective serotonin-uptake inhibitor, in the treatment of obesity: a dose-response study (with a commentary by Michael Weintraub)
L R Levine, G G Enas, W L Thompson, et al.
Journal of the American Academy of Child and Adolescent Psychiatry
|
April 21, 2001
The DISC Predictive Scales (DPS): efficiently screening for diagnoses
C P Lucas, H Zhang, P W Fisher, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 51) with videos related to
Sort By:
Page
of 6
Transactions of the American Association of Genito-Urinary Surgeons
|
January 1, 1972
The syndrome of hypertension, hyperreninemia and secondary aldosteronism associated with renal juxtaglomerular cell tumor (primary reninism)
J W Conn, E L Cohen, W J McDonald, et al.
The Journal of Urology
|
March 1, 1973
The syndrome of hypertension, hyperreninemia and secondary aldosteronism associated with renal juxtaglomerular cell tumor (primary reninism)
J W Conn, E L Cohen, W J McDonald, et al.
Clinical Science and Molecular Medicine. Supplement
|
August 1, 1973
Primary reninism: hypertension, hyperreninaemia and secondary aldosteronism due to juxtaglomerular renal cell tumours
J W Conn, E L Cohen, W J McDonald, et al.
The Journal of Laboratory and Clinical Medicine
|
November 1, 1971
Visualization of aldosterone-producing tumors (APT) by scintillation scanning (SS) employing tracer amounts of 131 -iodocholesterol
J W Conn, E L Cohen, C P Lucas, et al.
Obesity Research
|
August 4, 1998
Clinical trial design for obesity agents: a workshop report
J W Anderson, F X Pi-Sunyer, E Danforth, et al.
Archives of Internal Medicine
|
November 1, 1972
Primary reninism. Hypertension, hyperreninemia, and secondary aldosteronism due to renin-producing juxtaglomerular cell tumors
J W Conn, E L Cohen, C P Lucas, et al.
Transactions of the Association of American Physicians
|
January 1, 1972
The syndrome of hypertension, hyperreninemia and secondary aldosteronism associated with renal juxtaglomerular cell tumor (primary reninism)
J W Conn, E L Cohen, W J McDonald, et al.
JAMA
|
January 26, 1999
Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat: a randomized controlled trial
M H Davidson, J Hauptman, M DiGirolamo, et al.
International Journal of Obesity
|
January 1, 1989
Use of fluoxetine, a selective serotonin-uptake inhibitor, in the treatment of obesity: a dose-response study (with a commentary by Michael Weintraub)
L R Levine, G G Enas, W L Thompson, et al.
Journal of the American Academy of Child and Adolescent Psychiatry
|
April 21, 2001
The DISC Predictive Scales (DPS): efficiently screening for diagnoses
C P Lucas, H Zhang, P W Fisher, et al.
Page
of 6